In our study, we found through bioinformatics analyses that KCNK2, KCNK9, KCNK15, and KCNK17 mRNA and protein levels can be used as diagnostic biomarkers in HCC and predict patient prognosis. This evidence concerns the gene KCNK15 and hepatocellular carcinoma.